Skip to Main content Skip to Navigation
Journal articles

Enzyme replacement therapy for pancreatic insufficiency: present and future.

Aaron Fieker 1 Jessica Philpott 1 Martine Armand 2, * 
* Corresponding author
1 Division of Digestive Diseases
Division of Digestive Diseases
2 "Nutrition Humaine et Lipides"
Nutrition humaine et lipides : Biodisponibilité, métabolisme et régulation
Abstract : Pancreatic enzyme replacement therapy is currently the mainstay of treatment for nutrient malabsorption secondary to pancreatic insufficiency. This treatment is safe and has few side effects. Data demonstrate efficacy in reducing steatorrhea and fat malabsorption. Effective therapy has been limited by the ability to replicate the physiologic process of enzyme delivery to the appropriate site, in general the duodenum, at the appropriate time. The challenges include enzyme destruction in the stomach, lack of adequate mixing with the chyme in the duodenum, and failing to deliver and activate at the appropriate time. Treatment is begun when clinically significant malabsorption occurs resulting in steatorrhea and weight loss. Treatment failure is addressed in a sequential fashion. Current research is aimed at studying new enzymes and delivery systems to improve the efficiency of action in the duodenum along with developing better means to monitor therapy.
Complete list of metadata

Cited literature [197 references]  Display  Hide  Download
Contributor : Martine Armand Connect in order to contact the contributor
Submitted on : Friday, May 25, 2012 - 6:08:55 PM
Last modification on : Friday, September 24, 2021 - 3:08:02 PM
Long-term archiving on: : Sunday, August 26, 2012 - 3:00:53 AM


Publisher files allowed on an open archive




Aaron Fieker, Jessica Philpott, Martine Armand. Enzyme replacement therapy for pancreatic insufficiency: present and future.. Clinical and Experimental Gastroenterology, Dove Medical Press, 2011, 4 (4), pp.55-73. ⟨10.2147/CEG.S17634⟩. ⟨inserm-00701598⟩



Record views


Files downloads